Literature DB >> 9122854

[Regression of Yoshida sarcoma during normoxia and hypoxia after fractionated irradiation].

V Strnad1, F Kamprad, J Jahns, M Meyer, R Böhme, P Madaj-Sterba, M Kirschner, R Sauer.   

Abstract

PURPOSE: Tumor regression is one of the most important factors determinating the tumor control probability after radiotherapy. The changes in the regression of tumors during fractionated radiotherapy and the application of different radioprotectors or radiosensitizers make render to assess their effectivity. MATERIAL AND
METHOD: The effect of hypoxic breathing (8.1% O2) on the tumor regression of Yoshida sarcoma was studied using rats of Wistar strain. Different fractionation schedules were used: 10 x 3 Gy, 6 x 5 Gy and 3 x 10 Gy.
RESULTS: No significant changes in the tumor regression after radiotherapy in any group in any time independent from respiratoric hypoxia were recorded. The tumor regression rate was significantly influenced by treatment schedule (p < 0.0005).
CONCLUSIONS: Our results support the hypothesis of hypoxy-radiotherapy: The acute hypoxic hypoxia, caused due the breathing of hypoxic gas mixture with 8 to 10% oxygen, did not influence the radiation induced tumor regression in animal experiment. For this criterium no protection can be shown. The influence of hypoxy-radiotherapy on the local tumor control is necessary to evaluate in further experiments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122854     DOI: 10.1007/bf03039271

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  27 in total

1.  The prognostic significance of tumor response during radiotherapy in cervical carcinoma.

Authors:  I Grossman; S S Kurohara; J H Webster; F W George
Journal:  Radiology       Date:  1973-05       Impact factor: 11.105

2.  The relationship between the 'cell loss factor' and the immediate response to radiation in animal tumours.

Authors:  J Denekamp
Journal:  Eur J Cancer       Date:  1972-06       Impact factor: 9.162

3.  Radiation-induced tumor regression in carcinoma of the uterine cervix: prognostic significance.

Authors:  V A Marcial; A Bosch
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1970-01

4.  [Daytime related difference of radiation effect in rats with Yoshida sarcoma].

Authors:  K Fochem; W Michalica; E Picha
Journal:  Strahlentherapie       Date:  1967-04

5.  Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.

Authors:  I Lee; S H Levitt; C W Song
Journal:  Radiat Res       Date:  1987-10       Impact factor: 2.841

6.  Effect of Yoshida ascites tumour on the circulation in rats.

Authors:  T V Nguyen; K Albert; A Karai; I Szarvassy; L Takács
Journal:  Acta Physiol Hung       Date:  1985

7.  Effects of a modified CMF treatment (cyclophosphamide, methotrexate and 5-fluorouracil) on hematopoietic tissues and Yoshida sarcoma in rats.

Authors:  K Savovski; N Pujić; V Vranić; B Dimitrijević
Journal:  Acta Oncol       Date:  1994       Impact factor: 4.089

8.  Human cervical cancer clearance after 252Cf neutron brachytherapy versus conventional photon brachytherapy.

Authors:  Y Maruyama; W Muir
Journal:  Am J Clin Oncol       Date:  1984-08       Impact factor: 2.339

Review 9.  Effects of hyperglycemia and hyperthermia on the pH, glycolysis, and respiration of the Yoshida sarcoma in vivo.

Authors:  J A Dickson; S K Calderwood
Journal:  J Natl Cancer Inst       Date:  1979-12       Impact factor: 13.506

10.  Effect of small doses of 252Cf on the tumour regression in cervix uteri during combined radiotherapy.

Authors:  T Tacev; B Prokes; V Strnad; O Rasovská; V Krystof; D Nikodémová
Journal:  Strahlenther Onkol       Date:  1989-12       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.